Skip to main navigation
 
Search
Zentalis
Top Navigation
  • About Us
    • Our Company
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
      • Business Advisory Board
      • Partners & Collaborations
    • Contact Us
  • Our Pipeline
    • Pipeline
      • ZN-c3
      • ZN-d5
    • Clinical Trials
  • Our Approach
    • Integrated Discovery Engine
    • Supporting Publications
  • Investors & Media
    • Investor Home
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials & Filings
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Scientific Advisory Committee
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Investor Contact
      • Email Alerts
  • Careers
    • Why Zentalis?
    • Job Opportunities

Investors & Media

SEC Filing Details

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 1, 2023
Document Date
Dec 31, 2022
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Investors/Media

  • Investor Home
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Scientific Advisory Committee
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Investor Contact
    • Email Alerts

Investor Contact

Adam Levy
Senior Vice President,
Investor Relations
alevy@zentalis.com

Alexandra Roy
Solebury Strategic Communications
aroy@soleburystrat.com

Media Contact

Julia Deutsch
Solebury Strategic Communications
jdeutsch@soleburystrat.com

“The sun is but a morning star.”

Zentalis Logo

Corporate Office

1359 Broadway
Suite 1710
New York, NY 10018

Science Center

10275 Science Center Dr.
Suite 200
San Diego, CA 92121

For More Information

1-212-433-3791
info@zentalis.com
Footer
  • Privacy Policy
  • Terms of Use
  • Expanded Access Policy
  • Site Map

Copyright © 2023 Zentalis Pharmaceuticals. All Rights Reserved.